These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 39206186)

  • 1. Optimizing sheep B-cell epitopes in
    Yang J; Lv Y; Zhu Y; Song J; Zhu M; Wu C; Fu Y; Zhao W; Zhao Y
    Front Immunol; 2024; 15():1451538. PubMed ID: 39206186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoprotection of recombinant Eg.P29 against Echinococcus granulosus in sheep.
    Wang H; Li Z; Gao F; Zhao J; Zhu M; He X; Niu N; Zhao W
    Vet Res Commun; 2016 Jun; 40(2):73-9. PubMed ID: 27094043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of B-cell dominant epitopes in the recombinant protein P29 from Echinococcus granulosus.
    Lv Y; Li S; Zhang T; Zhu Y; Tao J; Yang J; Chang L; Wu C; Zhao W
    Immun Inflamm Dis; 2022 May; 10(5):e611. PubMed ID: 35478448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA028466 regulates Th1/Th2 cytokine expression and associates with Echinococcus granulosus antigen P29 immunity.
    Wang C; Yang SH; Niu N; Tao J; Du XC; Yang JH; Zhu MX; Wang YN; Zhao W
    Parasit Vectors; 2021 Jun; 14(1):295. PubMed ID: 34082780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-374b-5p Regulates T Cell Differentiation and Is Associated with rEg.P29 Immunity.
    Li D; Du X; Zhu M; Yang S; Zhao W
    Biomed Res Int; 2020; 2020():8024763. PubMed ID: 32908913
    [No Abstract]   [Full Text] [Related]  

  • 6. Design of a Novel Multi-Epitope Vaccine Against
    Yu M; Zhu Y; Li Y; Chen Z; Sha T; Li Z; Zhang F; Ding J
    Front Immunol; 2021; 12():668492. PubMed ID: 34456902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a dominant murine T-cell epitope in recombinant protein P29 from Echinococcus granulosus.
    Lv Y; Zhu Y; Chang L; Yang J; Zhao Y; Zhao J; Wang Y; Zhu M; Wu C; Zhao W
    Acta Biochim Biophys Sin (Shanghai); 2022 Apr; 54(4):482-493. PubMed ID: 35607954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant antigen P29 of
    Yang J; Zhao Y; Fu Y; Lv Y; Zhu Y; Zhu M; Zhao J; Wang Y; Wu C; Zhao W
    Front Immunol; 2023; 14():1243204. PubMed ID: 38187382
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenicity of peptide-based vaccine composed of epitopes from Echinococcus granulosus rEg.P29.
    Lv Y; Chang L; Yang J; Wen J; Zhao Y; Zhu M; Wu C; Zhao W
    FASEB J; 2023 Apr; 37(4):e22819. PubMed ID: 36848174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in intestinal flora of mice induced by rEg.P29 epitope peptide vaccines.
    Zhang T; Lv Y; Zhao Y; Yang J; Qian B; Zhu Y; Zhao W; Zhu M
    Immun Inflamm Dis; 2023 Nov; 11(11):e1082. PubMed ID: 38018604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic differences between the EG95-related proteins from Echinococcus granulosus G1 and G6 genotypes: implications for vaccination.
    Alvarez Rojas CA; Gauci CG; Lightowlers MW
    Parasite Immunol; 2013 Feb; 35(2):99-102. PubMed ID: 23009356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and antibodies against Echinococcus granulosus recombinant antigen P29 in patients with cystic echinococcosis in China.
    Tao J; Du X; Liu K; Wang C; Lv Y; Wang M; Yang Z; Yang J; Li S; Wu C; Li M; Zhao W
    BMC Infect Dis; 2022 Jul; 22(1):609. PubMed ID: 35820830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Recombinant
    Du X; Zhu M; Zhang T; Wang C; Tao J; Yang S; Zhu Y; Zhao W
    Front Immunol; 2022; 13():773276. PubMed ID: 35211114
    [No Abstract]   [Full Text] [Related]  

  • 14. Serological monitoring of protection of sheep against Echinococcus granulosus induced by the EG95 vaccine.
    Heath DD; Koolaard J
    Parasite Immunol; 2012 Jan; 34(1):40-4. PubMed ID: 22043983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cloning and expression of echinococcus granulosus Eg18 and preliminary evaluation of immunological assay with recombinant antigen].
    Wang YS; Han XM; Wang H
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Apr; 23(2):192-6. PubMed ID: 22164626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic peptides induce antibody against a host-protective antigen of Echinococcus granulosus.
    Woollard DJ; Gauci CG; Lightowlers MW
    Vaccine; 1999 Dec; 18(9-10):785-94. PubMed ID: 10580190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity in mice of recombinant BCG-EgG1Y162 vaccine for Echinococcus granulosus infection.
    Ma X; Zhao H; Zhang F; Zhu Y; Peng S; Ma H; Cao C; Xin Y; Yimiti D; Wen H; Ding J
    Hum Vaccin Immunother; 2016; 12(1):170-5. PubMed ID: 26266551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echinococcus granulosus: variability of the host-protective EG95 vaccine antigen in G6 and G7 genotypic variants.
    Chow C; Gauci CG; Vural G; Jenkins DJ; Heath DD; Rosenzvit MC; Harandi MF; Lightowlers MW
    Exp Parasitol; 2008 Aug; 119(4):499-505. PubMed ID: 18342311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a novel EmTSP-3 and EmTIP based multi-epitope vaccine against
    Fan Y; He Y; Li Y; Yin Z; Shi J; Tian T; Shang K; Shi H; Zhang F; Wen H
    Front Immunol; 2024; 15():1425603. PubMed ID: 39351224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with rEGVac elicits immunoprotection against different stages of Echinococcus granulosus life cycle: A pilot study.
    Pourseif MM; Moghaddam G; Nematollahi A; Khordadmehr M; Naghili B; Dehghani J; Omidi Y
    Acta Trop; 2021 Jun; 218():105883. PubMed ID: 33676937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.